What is the dosage of IXEMPRA?

IXEMPRA is available in 2 dosages, including 15 mg Injection and 45 mg Injection

What does IXEMPRA treat?

IXEMPRA treats Breast Neoplasms

What is IXEMPRA made of?

IXEMPRA contains ixabepilone which is a Microtubule Inhibitor

How is IXEMPRA administered?

IXEMPRA is administered as a Injectable

Dosage & Administration Efficacy safety testing Drug label Prior authorization Financial assistance

Patient education

Ixempra

(ixabepilone)

ixabepilone 15 MG Injection [IXEMPRA]ixabepilone 45 MG Injection [IXEMPRA]

BLACK BOX WARNING

Dosage & administration

* The recommended dosage of IXEMPRA is 40 mg/m 2 administered as a 3-hour intravenous infusion once every 3 weeks ( 2.2).

Dose reduction is required in patients with elevated AST, ALT, or bilirubin.( 2.3, 8.6)

* IXEMPRA must be reconstituted with the supplied DILUENT and further diluted to a concentration of 0.2 mg/mL to 0.6 mg/mL prior to administration ( 2.6).

eficacy, safety & testing

Ixempra clinical details

Mechanism of Action (MOA)

Clinical Trial, Efficacy & Safety Profile

Dosing & Administration

drug label

Ixempra prescribing information

Need to report an Ixempra issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Ixempra Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

Ixempra Enrollment Form

Patient Authorization Form

Patient Authorization Form - Spanish

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Ixempra Financial assistance options

Co-pay savings program

commercial only

Ixempra Enrollment Form

Patient Authorization Form

Patient Authorization Form - Spanish

Enroll in Patient Savings Progam

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Ixempra Enrollment Form

Patient Authorization Form

Patient Authorization Form - Spanish

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Ixempra Patient education

Getting started on Ixempra

NOT PROVIDED BY BRANDInstructions For Use: Metastatic Breast Cancer

Patient toolkit

Patient Resources

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Brochure - Spanish

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Side Effects Tracker

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Ixempra FAQs

FAQ Data Source

Can't find what you're looking for?

Our trained staff can help you:

Please note:

Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.

Ixempra

Dosage & administration

eficacy, safety & testing

Ixempra clinical details

drug label

Ixempra prescribing information

Need to report an Ixempra issue?

prior authorization

Ixempra Prior authorization resources

Benefits investigation

Reimbursement help (FRM)

financial assistance

Ixempra Financial assistance options

Co-pay savings program

Bridge program

Foundation programs

patient education

Ixempra Patient education

Getting started on Ixempra

Patient toolkit

people also ask

Ixempra FAQs

Can't find what you're looking for?